JOEL LEWIS - President and CEO, Director at GALECTIN THERAPEUTICS INC

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
GALT on Nasdaq
All Insider Reports
All Insider Reports

JOEL LEWIS - trading volume in the past year for GALECTIN THERAPEUTICS INC

Holdings reported by JOEL LEWIS for GALECTIN THERAPEUTICS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 833K $5.87M $7.06 17 Dec 2025 Direct
Restricted Stock Unit 84K $97.4K $1.16 23 Jan 2025 Direct Common Stock
Stock option (right to buy) 32.2K $96.2K $2.39 17 Dec 2025 Direct Common Stock
Common Stock 2K $11.1K $5.53 17 Dec 2025 as USTA custodian for a minor child
Restricted Stock Units 0 $0 $0.82 23 Dec 2024 Direct Common Stock

Transactions reported by JOEL LEWIS for GALECTIN THERAPEUTICS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.